Unirajine Tablet (Epinastine Hydrochloride)

Adult dose

1. Asthma, urticaria, eczema/dermatitis, itchy skin, prurigo, and pruritic psoriasis vulgaris Adults: Administer 20 mg of epinastine hydrochloride orally once daily. Adjust the dose appropriately according to symptoms. 2. Allergic rhinitis Adults: Administer 10～20 mg of this medicine orally once daily. Adjust the dose appropriately according to symptoms.

This medication should not be used in patients who have had an allergic reaction to this medication or any of its components. Caution is advised when administering this medication to patients with liver disease or a history of liver disease, as liver function may worsen. If allergic symptoms such as rash, urticaria, swelling of the face or extremities, or itching occur during use, stop taking the medication immediately and seek appropriate treatment. This medication may cause drowsiness, headache, and dizziness, so caution is needed when driving or operating machinery. Gastrointestinal symptoms such as dyspepsia, nausea, abdominal pain, and dry mouth may occur; if symptoms are severe, consult a doctor. Liver function abnormalities or jaundice may occur, so liver function should be monitored regularly, and if abnormalities are found, discontinue use. Caution is needed in patients with kidney disease, as it may affect kidney function. Urinary symptoms such as abnormal urine, frequent urination, or hematuria may occur, so symptoms should be monitored. Patients with heart disease should be cautious as symptoms such as rapid heartbeat may occur. Respiratory symptoms such as shortness of breath or nasal congestion may rarely occur. Blood tests may show decreased platelets or increased white blood cells, so report any unusual symptoms to medical personnel immediately. In women, symptoms such as gynecomastia, menstrual disturbances, or breast pain may rarely occur. This medication is not intended for the rapid relief of asthma attacks, so asthma patients should understand this before use. Patients undergoing long-term steroid treatment should gradually reduce their steroid dosage while taking this medication, under the supervision of a healthcare provider. This medication may cause drowsiness, so caution is needed when driving or operating machinery. Do not take this medication long-term if the effect is not confirmed. Patients with seasonal allergies should begin taking this medication before the symptoms start to prevent worsening symptoms. This medication does not enhance the sedative effects when used with other sleep aids, antihistamines, or alcohol, but caution is still advised due to limited combined experience. Safety has not been established during pregnancy; women who are pregnant or may become pregnant should consult a doctor before use. Women who are breastfeeding should either avoid this medication due to the potential for transfer in breast milk or discontinue breastfeeding while using this medication. Safety in children, especially newborns or infants, has not been adequately established, so caution is needed for use. In the elderly, liver and kidney functions may be impaired, so closely monitor for unusual symptoms and adjust the dosage as necessary. In overdose situations, serious side effects such as cardiac rhythm abnormalities may occur; if overdose is suspected, immediate medical attention is required. This medication should be kept out of reach of children and should not be transferred to another container for safety.

• Allergic reactions
• rash
• hives
• redness
• itching
• swelling
• erythema accompanied by itching
• drowsiness
• lethargy
• headache

This medication should be stored in a tightly sealed container to protect it from air and moisture. Additionally, it is best to store the medication at room temperature between 1 degree and 30 degrees, avoiding extremely hot or cold places.

Appearance

White or light yellow round film-coated tablet

Package unit

30 tablets/bottle, 200 tablets/bottle